Trevi Therapeutics, Inc.
TRVI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001563880
In the last 90 days, Trevi Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 218 institutions reported holding it in 13F filings for Q2 2026, worth $2.76B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q3 2022
Institutional positions in Trevi Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +8 vs. Q2 2022
- Shares held
- 45.8M
- +17.0M (+59.2%) vs. Q2 2022
- Total value
- $70.5M
- −$10.3M (−12.7%) vs. Q2 2022
- New holders
- 11
- 14 more added
- Sold out
- 3
- 10 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRVI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 218 | $2.76B |
| Q1 2026 | 198 | $1.61B |
| Q4 2025 | 184 | $1.63B |
| Q3 2025 | 164 | $1.18B |
| Q2 2025 | 154 | $627.2M |
| Q1 2025 | 137 | $554.3M |
| Q4 2024 | 110 | $329.5M |
| Q3 2024 | 93 | $194.1M |
| Q2 2024 | 77 | $166.6M |
| Q1 2024 | 80 | $177.9M |
| Q4 2023 | 63 | $70.0M |
| Q3 2023 | 55 | $106.1M |
| Q2 2023 | 53 | $116.7M |
| Q1 2023 | 36 | $80.4M |
| Q4 2022 | 37 | $83.3M |
| Q3 2022 | 40 | $70.5M |
| Q2 2022 | 32 | $80.8M |
| Q1 2022 | 23 | $32.9M |
| Q4 2021 | 17 | $10.3M |
| Q3 2021 | 18 | $17.4M |
| Q2 2021 | 17 | $28.1M |
| Q1 2021 | 19 | $35.6M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Trevi Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 11,373,174 | $17.5M | 0.87% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 5,696,515 | $8.77M | 1.62% | +4,072,126+250.7% | Added |
| Rubric Capital Management LP | 5,684,420 | $8.75M | 0.44% | +3,906,000+219.6% | Added |
| Frazier Life Sciences Management, L.P. | 5,403,590 | $8.32M | 0.64% | +4,231,963+361.2% | Added |
| Viking Global Investors LPSuperinvestorViking Global Investors | 4,400,000 | $6.78M | 0.03% | +4,400,000 | New |
| VR Adviser, LLC | 3,050,022 | $4.70M | 0.72% | 00.0% | Unchanged |
| MAI Capital Management | 2,019,164 | $3.11M | 0.06% | −20,845−1.0% | Reduced |
| FMR LLC | 1,560,125 | $2.40M | 0.00% | +1,476,900+1,774.6% | Added |
| Vanguard Group Inc | 1,324,377 | $2.04M | 0.00% | +1,087,437+459.0% | Added |
| Altium Capital Management LP | 1,066,157 | $1.64M | 0.62% | −217,843−17.0% | Reduced |
| Silverarc Capital Management, LLC | 939,265 | $1.45M | 0.61% | +939,265 | New |
| Armistice Capital, LLC | 864,000 | $1.33M | 0.03% | +448,000+107.7% | Added |
| Morgan Stanley | 428,405 | $660.0K | 0.00% | +428,405 | New |
| Renaissance Technologies LLC | 419,187 | $646.0K | 0.00% | +267,687+176.7% | Added |
| TPG GP A, LLC | 251,780 | $388.0K | 0.01% | −4,073,103−94.2% | Reduced |
| Geode Capital Management, LLC | 200,221 | $308.0K | 0.00% | +5,075+2.6% | Added |
| Bridgeway Capital Management, LLC | 159,300 | $245.0K | 0.01% | +56,700+55.3% | Added |
| Marshall Wace, LLP | 128,324 | $198.0K | 0.00% | +128,324 | New |
| WealthTrust Axiom LLC | 93,500 | $143.0K | 0.05% | 00.0% | Unchanged |
| J. Goldman & Co LP | 89,188 | $137.0K | 0.01% | −45,812−33.9% | Reduced |
| Hillsdale Investment Management Inc. | 86,531 | $133.0K | 0.01% | +86,531 | New |
| Two Sigma Investments, LP | 79,437 | $122.0K | 0.00% | +79,437 | New |
| State Street Corp | 77,042 | $119.0K | 0.00% | +37,200+93.4% | Added |
| EAM Investors, LLC | 58,202 | $90.0K | 0.02% | −315,041−84.4% | Reduced |
| BlackRock Inc. | 58,824 | $90.0K | 0.00% | +1,330+2.3% | Added |
| Jump Financial, LLC | 42,977 | $66.0K | 0.00% | +42,977 | New |
| Millennium Management LLC | 39,961 | $62.0K | 0.00% | −26,222−39.6% | Reduced |
| Northern Trust Corp | 39,927 | $61.0K | 0.00% | −6,371−13.8% | Reduced |
| Acuta Capital Partners, LLC | 36,302 | $56.0K | 0.02% | +1,302+3.7% | Added |
| United Bank | 28,450 | $44.0K | 0.01% | 00.0% | Unchanged |
| LPL Financial LLC | 20,000 | $31.0K | 0.00% | +10,000+100.0% | Added |
| Bank of New York Mellon Corp | 14,098 | $22.0K | 0.00% | +14,098 | New |
| Charles Schwab Investment Management Inc | 12,557 | $20.0K | 0.00% | 00.0% | Unchanged |
| Credit Suisse AG | 10,374 | $16.0K | 0.00% | +10,374 | New |
| Tower Research Capital LLC (TRC) | 9,786 | $15.0K | 0.00% | +5,912+152.6% | Added |
| UBS Group AG | 4,277 | $7.00K | 0.00% | −494−10.4% | Reduced |
| First Manhattan Co | 1,500 | $2.00K | 0.00% | −1,000−40.0% | Reduced |
| Federated Hermes, Inc. | 872 | $1.00K | 0.00% | +872 | New |
| Wells Fargo & Company | 139 | $0 | 0.00% | −27−16.3% | Reduced |
| Royal Bank of Canada | 149 | $0 | 0.00% | +149 | New |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −7,986−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1,700−100.0% | Sold out |
| Curi Capital | 0 | $0 | 0.00% | −998−100.0% | Sold out |